Commercial Excellence 
As we reach mid-year, specialty pharmaceutical companies face a critical question: Is your account management approach succeeding in today’s complex healthcare ecosystem?
Why Account Management Is “Complicated” in Specialty Pharma
The traditional primary care account management playbook simply doesn’t work in specialty markets. While primary care relies on broad, high-volume engagement with general practitioners, specialty pharma operates in an ecosystem where the identification of patients, use of clinical pathways, and access barriers determine if a patient receives treatment. Add to the complexity the decisions, processes and stakeholders involved in the distribution, handling, storing, administering and reimbursing medications.
Integrated Delivery Networks represent the ultimate complexity test for specialty account management. The old saying “when you’ve seen one IDN, you’ve seen one IDN” has never been truer, but, as the number of specialty medications within the marketplace has increased, so too has the sophistication required when engaging with IDNs. It used to be that simply engaging the provider or the academic center regarding your specialty medication was enough to get patients started on therapy. Today, as many of these Academic Medical Centers (and their HCPs) are now part of larger IDNs, access strategy and pull-through is substantially more complex.
The Current Reality: What’s Changed
The financial pressure created by specialty drug costs has fundamentally altered the decision-making landscape. Pharmacy and Therapeutics committees now wield enhanced authority over specialty products, while new roles have emerged specifically to manage the economic impact of high-cost therapies. Data analytics teams track outcomes and utilization patterns with unprecedented sophistication, and financial decision-makers require comprehensive economic justification for specialty drug adoption.
The evaluation of specialty partnerships is based on the ability to deliver measurable outcomes across multiple dimensions:
- Clinical outcomes: Real-world evidence for specialty populations
- Operational efficiency: Streamlined administration and monitoring processes
- Total cost of care: Economic impact across the complete patient journey
- Risk management: Comprehensive safety monitoring and adverse event protocols
- Patient experience: Integrated support services and access programs
These expectations require pharmaceutical companies to develop more comprehensive and evidence-based value propositions that address the full scope of IDN concerns and priorities.
Account Management Framework for Specialty Success
Multi-Dimensional Stakeholder Mapping
Successful specialty account management begins with understanding the complex stakeholder environment. At the executive level, conversations center on strategic partnership opportunities around complex care delivery models. Service line leadership focuses on clinical and operational efficiency for specialty patient populations, while P&T committees demand rigorous evidence for specialty drug evaluation.
The stakeholder map extends beyond traditional clinical decision-makers to include specialty pharmacy teams who need operational logistics and clinical teams who require education on complex treatment protocols and patient support. Each group brings different priorities, concerns, and decision-making authority that must be understood and addressed.
Account Planning Complexity
Each IDN requires a tailored approach based on its unique characteristic and the different decision-making processes. The level of centralization varies significantly across service lines, creating a complex matrix of relationships and influences.
Reimbursement landscapes add another layer of complexity, with medical benefit versus pharmacy benefit determinations affecting access strategies. Specialized clinical protocols and treatment pathways must be understood and integrated into account plans, along with patient access and support service requirements that vary by therapeutic area. Technology adoption varies significantly across IDNs, affecting their analytics capabilities and data integration sophistication.
Cross-functional Collaboration
The cross-functional coordination required for specialty account management goes far beyond traditional sales team collaboration:
- Account management leads must outline the account strategy and focus on strengthening relationships to deliver value and improve outcomes
- Sales teams engage with the providers within the various functions for the purpose of driving clinical conviction around the value of the product and helping to identify the appropriate patient types.
- Field-based medical provides sophisticated scientific discussions and real-world evidence with clinical leaders to inform clinical strategy.
- Market access teams navigate the intricate coverage, prior authorization, and contracting landscape that can make or break specialty product success.
- Field Reimbursement teams help to ensure prior authorizations and reimbursement challenges are overcome
- Nurse educators or other teams must integrate support programs seamlessly to ensure optimal patient outcomes and satisfaction.
The Path Forward
The complexity of specialty pharma account management is undeniable, but so is the opportunity for companies that develop sophisticated capabilities. Success requires building deep understanding of each IDN’s unique characteristics and decision-making processes, while developing comprehensive approaches that address clinical, operational, and financial considerations simultaneously.
Seamless coordination across the account team enables the delivery of integrated solutions that IDNs’ value, and continuous adaptation ensures strategies remain relevant as IDNs evolve their specialty care approaches. The investment required to develop these sophisticated account management capabilities will be rewarded with stronger partnerships, better access, and ultimately superior patient outcomes.
Companies that embrace this complexity and develop the capabilities to navigate it successfully will differentiate themselves in an increasingly competitive specialty marketplace. The question isn’t whether account management in specialty pharma is complicated—it’s whether your organization has the sophistication to make it work.
Join us at LTEN for “It’s Complicated: Making Account Management Work in Specialty Pharma” to explore these strategies in detail and learn from real-world implementation examples.
For insights on developing sophisticated account management capabilities, visit wlhconsulting.com or stop by booth [#] at LTEN to discuss your specific challenges.
